Biotalk

Biotalk Episode 20: A Conversation with David Harel of CytoReason

34:01

On this episode of BioTalk, Geoff Meyerson, CEO of Locust Walk, sits down with David Harel, CEO and Co-founder of CytoReason. CytoReason uses AI-powered disease models to transform drug discovery and development, offering pharmaceutical companies insights that reduce both time and costs in bringing new therapies to market.

David shares his journey from private equity to co-founding…